A. Turner (Birmingham (West Midlands), United Kingdom), K. Chapman (Toronto (ON), Canada)
Prevalence of cardiovascular disease in alpha-1 antrypsin deficiency
E. Bailey (Birmingham (West Midlands), United Kingdom), P. Ellis (Birmingham (West Midlands), United Kingdom), A. Turner (Birmingham (West Midlands), United Kingdom), P. Ellis (Solihull, United Kingdom)
|   |
Alpha-1 antitrypsin deficiency associates with asthma exacerbations
E. Martín González (La Laguna, Spain), J. Hernández-Pérez (Breña alta, Spain), . González-Carracedo (La Laguna, Spain), J. Pérez-García (La Laguna, Spain), R. González-Pérez (La Laguna, Spain), E. Mederos-Luis (La Laguna, Spain), I. Sánchez-Machín (La Laguna, Spain), P. Poza-Guedes (La Laguna, Spain), M. Jesús Cruz (Madrid, Spain), F. González-Barcala (La Coruña, Spain), C. Martínez-Rivera (Barcelona, Spain), J. Mullol (Barcelona, Spain), X. Muñoz (Madrid, Spain), J. Olaguibel (Madrid, Spain), V. Plaza (Madrid, Spain), S. Quirce (Madrid, Spain), A. Valero (Madrid, Spain), J. Sastre (Madrid, Spain), V. Del Pozo (Madrid, Spain), J. Villar (Madrid, Spain), J. Pérez (La Laguna, Spain), M. Pino-Yanes (La Laguna, Spain)
| |
The effect of SERPINA1 mutations on a1-antitrypsin levels in COPD
C. Páska (Budapest, Hungary), I. Barta (Budapest, Hungary), A. Kecskés (Budapest, Hungary), A. Kerpel-Fronius (Budapest, Hungary), D. Solymosi (Budapest, Hungary), B. Antus (Budapest, Hungary)
| |
Association between a1-antitrypsin deficiency and its clinical manifestations – an observational study in a Portuguese cohort
M. Silva (Leiria, Portugal), D. Amorim (Leiria, Portugal), M. Canotilho (Leiria, Portugal), S. Feijó (Leiria, Portugal)
| |
Longitudinal follow-up in adults with severe alpha-1 antitrypsin deficiency (Pi*ZZ genotype): non-invasive fibrosis tests predict liver-related endpoints
M. Fromme (Aachen, Germany), S. Amzou (Aachen, Germany), B. Burbaum (Aachen, Germany), P. Striedl (Salzburg, Austria), M. Mandorfer (Vienna, Austria), M. Pons (Barcelona, Spain), J. Genesca (Barcelona, Spain), M. Miravitlles (Barcelona, Spain), E. Aigner (Salzburg, Austria), C. Trautwein (Aachen, Germany), P. Strnad (Aachen, Germany)
| |
The effect of alpha-1 antitrypsin (AAT) augmentation therapy on the liver phenotype in individuals with homozygous Pi*Z AAT mutation (genotype Pi*ZZ)
M. Fromme (Aachen, Germany), K. Hamesch (Aachen, Germany), C. Schneider (Aachen, Germany), M. Mandorfer (Vienna, Austria), K. Holtz-Thorhauge (Odense, Denmark), V. Pereira (Funchal, Portugal), M. Pons (Barcelona, Spain), M. Reichert (Homburg, Germany), S. Amzou (Aachen, Germany), R. Bals (Homburg, Germany), R. Koczulla (Marburg, Germany), M. Miravitlles (Barcelona, Spain), S. Janciauskiene (Hannover, Germany), J. Genesca (Barcelona, Spain), F. Benini (Brescia, Italy), J. Chorostowska-Wynimko (Warsaw, Poland), W. Griffiths (Cambridge, United Kingdom), E. Aigner (Salzburg, Austria), A. Teumer (Greifswald, Germany), M. Trauner (Vienna, Austria), A. Krag (Odense, Denmark), C. Trautwein (Aachen, Germany), P. Strnad (Aachen, Germany)
| |
?1-ANTITRYPSIN DEFICIENCY IN GREEKS: FOCUS ON RARE VARIANTS
S. Papiris (Athens, Greece), M. Veith (Marburg, Germany), A. Papaioannou (Athens , Greece), V. Apollonatou (Athens , Greece), I. Ferrarotti (Pavia, Italy), S. Ottaviani (Pavia, Italy), . Tzouvelekis (Patras, Greece), . Tzilas (Athens , Greece), N. Rovina (Athens , Greece), . Stratakos (Athens , Greece), I. Gerogianni (Larissa, Greece), Z. Daniil (Larissa, Greece), L. Kolilekas (Athens , Greece), A. Tsaroucha (Athens , Greece), K. Dimakou (Athens , Greece), G. Pitsidianakis (Heraklion, Greece), N. Tzanakis (Heraklion, Greece), S. Tryfon (Thessaloniki , Greece), I. Papanikolaou (Corfu, Greece), M. Kitrou (Patras, Greece), A. Haritou (Ioannina, Greece), F. Fragopoulos (Nicosia, Cyprus), E. Antonogiannaki (Athens, Greece), A. Lazaratou (Athens, Greece), Z. Sardelis (Athens, Greece), E. Stagaki (Athens, Greece), G. Apollonatos (Athens, Greece), . Fouka (Thessaloniki, Greece), D. Papakosta (Thessaloniki, Greece), M. Tsiamita (Patras, Greece), P. Loukopoulou (Aigio , Greece), D. Tsoukas (Florina, Greece), S. Markou (Xanthi, Greece), P. Mavroudis (Athens, Greece), P. Emmanouil (Athens, Greece), N. Anagnostopoulos (Athens, Greece), T. Karampitsakos (Patras, Greece), I. Korbila (Athens , Greece), K. Vlami (Athens , Greece), G. Verykokou (Athens , Greece), M. Kallieri (Athens , Greece), G. Papadaki (Athens , Greece), M. Maniati (Athens , Greece), K. Kagouridis (Athens , Greece), P. Lyberopoulos (Athens , Greece), K. Douros (Athens , Greece), S. Fessatou (Athens , Greece), I. Kanavaki (Athens , Greece), V. Papaevangelou (Athens , Greece), I. Tsangaris (Athens , Greece), N. Koulouris (Athens , Greece), S. Loukides (Athens , Greece), D. Bouros (Athens , Greece), M. Balduyck (Lille, France), C. Lombard (Lyon, France), V. Cottin (Lyon, France), J. Mornex (Lyon, France), C. Vogelmeier (Marburg , Germany), T. Greulich (Marburg , Germany), E. Manali (Athens, Greece)
| |
Familiarity and use of ERN-LUNG centres for the management of Alpha 1 Antitrypsin Deficiency
J. Chorostowska-Wynimko (Warsaw, Poland), A. Koczulla (Marburg, Germany), M. Sucena (Porto, Portugal)
| |
Association between lung disease severity and cardiovascular event risk in alpha-1 antitrypsin deficiency
D. Spittle (Birmingham, United Kingdom), A. Pye (Birmingham, United Kingdom), P. Ellis (Birmingham, United Kingdom), A. Turner (Birmingham, United Kingdom)
| |
Heterozygous alpha 1 antitrypsin mutations (HA1AT) and lung cancer (LC) in a chronic obstructive pulmonary disease (COPD) population.
A. Marín Muñiz (L'Hospitalet de Llobregat, Spain), L. Méndez Mangas (L'Hospitalet de Llobregat, Spain), M. Navarro Rodríguez (L'Hospitalet de Llobregat, Spain), J. Burgos Lozano (L'Hospitalet de Llobregat, Spain), I. Brao Pérez (L'Hospitalet de Llobregat, Spain), M. Arellano Vengoechea (L'Hospitalet de Llobregat, Spain), M. López Sánchez (L'Hospitalet de Llobregat, Spain), S. Padrones Sánchez (L'Hospitalet de Llobregat, Spain), S. Aso González (L'Hospitalet de Llobregat, Spain), S. Santos Pérez (L'Hospitalet de Llobregat, Spain)
| |
Diagnosing Alpha 1 Antitrypsin Deficiency in Europe – insights from a European survey
M. Campos Miranda Duarte Sucena (Porto, Portugal), A. Koczulla (Marburg , Germany), J. Chorostowska-Wynimko (Warsaw, Poland)
| |
Clinical features of a severe asthma population eligible for biologics: a real life study
S. Garino (Turin, Italy), E. Riccardi (Turin, Italy), A. Sprio (Turin, Italy), F. Giannoccaro (Turin, Italy), A. Baroso (Turin, Italy), S. Pizzimenti (Turin, Italy), F. Ricciardolo (Turin, Italy)
| |
Predictors of fixed airflow obstruction (FAO) in patients with severe asthma (SA) in the Wessex Severe Asthma Cohort (WSAC)
V. Bataduwaarachchi (Portsmouth, United Kingdom), T. Brown (Portsmouth, United Kingdom), L. Wiffen (Portsmouth, United Kingdom), T. Jones (Portsmouth, United Kingdom), C. Barber (Southampton, United Kingdom), P. Howarth (Southampton, United Kingdom), A. Chauhan (Portsmouth, United Kingdom)
| |
Characteristics of patients and exacerbations in the ongoing Asthma: Phenotyping Exacerbations (APEX) studies.
A. Pradhan (Nottingham, United Kingdom), R. Needham (Nottingham, United Kingdom), K. Shaw (Nottingham, United Kingdom), M. Martin (Nottingham, United Kingdom), M. Portelli (Nottingham, United Kingdom), I. Sayers (Nottingham, United Kingdom), T. Harrison (Nottingham, United Kingdom)
| |
Infectious exacerbation of asthma
H. Arfaoui (casablanca, Morocco), S. Msika (casablanca, Morocco), H. Jabri (casablanca, Morocco), W. El Khattabi (casablanca, Morocco), H. Afif (casablanca, Morocco)
| |
Clinical features of asthmatics with high serum total IgE
M. Sciolla (Orbassano, Italy), A. Sprio (Orbassano, Italy), A. Baroso (Orbassano, Italy), G. Orpheu (Orbassano, Italy), C. La Sala (Orbassano, Italy), A. Di Stefano (Veruno, Italy), F. Ricciardolo (Orbassano, Italy)
| |
Small airway dysfunction assesed by forced oscillation technique
P. Singh (Lucknow, India), N. Ahuja (Lucknow, India), A. Yadav (Lucknow, India), S. Tiwari (Lucknow, India)
| |
How consistent are blood eosinophil counts in a general population?
S. Hartl (Vienna, Austria), M. Breyer (Vienna, Austria), O. Burghuber (Vienna, Austria), C. Schiffers (Vienna, Austria), P. Puchhammer (Vienna, Austria), A. Ofenheimer (Vienna, Austria), R. Breyer-Kohansal (Vienna, Austria)
| |
Late Breaking Abstract - Developing a point of care (POC) breath test to accurately predict asthma exacerbations
V. Higgs (London, United Kingdom), H. Ahmed (London, United Kingdom), J. Flavier (London, United Kingdom), F. Hegarzy (Liverpool, United Kingdom)
| |
Late Breaking Abstract - Clinical differences between male and female SEO-COPD patients
T. Kole (Groningen, Netherlands), J. Hartman (Groningen, Netherlands), D. Slebos (Groningen, Netherlands), M. Van Den Berge (Groningen, Netherlands)
| |